Alterity Therapeutics Ltd (ATHE) stock
ATHENasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRNAF
$1.86−0.09 (-4.85%)
Close on Nov 17, 2026Market cap $33.80MP/E –Yield –
Alterity Therapeutics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2018 it was A$201.17K, up 51.9% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2018 | Jun 30, 2018 | A$201.17K | +51.9% |
| FY2017 | Jun 30, 2017 | A$132.40K | -7.2% |
| FY2016 | Jun 30, 2016 | A$142.66K | – |
See a number that looks wrong?